Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × FED × Respiratory Distress Syndrome × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Small Cell Lung Carcinoma 1 Respiratory Distress Syndrome 1 Pneumonia 1 Ovarian Neoplasms 1 Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Bronchiolitis Obliterans 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00029328 2015-03-25

Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

FDA Office of Orphan Products Development

Phase 1/2 Completed

Bronchiolitis Obliterans, Pneumonia, Respiratory Distress Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡